Drugs / RSV vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07587801 Background | May → Jul 2026 overdue | — | Central Adelaide Local Health Network Incorporated | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RSV vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07587801 ↗ |
| Known as | Pfizer Abrysvo | “RSV vaccine (Pfizer Abrysvo)” NCT07587801 ↗ |
| Modality | Vaccine | “RSV vaccine (Pfizer Abrysvo)” NCT07587801 ↗ |